Literature DB >> 16969376

Sotos syndrome.

Katrina Tatton-Brown1, Nazneen Rahman.   

Abstract

Sotos syndrome is an autosomal dominant condition characterised by a distinctive facial appearance, learning disability and overgrowth resulting in tall stature and macrocephaly. In 2002, Sotos syndrome was shown to be caused by mutations and deletions of NSD1, which encodes a histone methyltransferase implicated in chromatin regulation. More recently, the NSD1 mutational spectrum has been defined, the phenotype of Sotos syndrome clarified and diagnostic and management guidelines developed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969376     DOI: 10.1038/sj.ejhg.5201686

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  41 in total

Review 1.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

2.  Deletion of NSD1 exon 14 in Sotos syndrome: first description.

Authors:  Maria Piccione; Valeria Consiglio; Antonella Di Fiore; Marina Grasso; Massimiliano Cecconi; Lucia Perroni; Giovanni Corsello
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

3.  Novel missense mutation (L1917P) involving sac-domain of NSD1 gene in a patient with Sotos syndrome.

Authors:  Francesco Nicita; Luigi Tarani; Alberto Spalice; Marina Grasso; Laura Papetti; Massimiliano Cecconi; Claudio Di Biasi; Fabiana Ursitti; Paola Iannetti
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 4.  Genetic syndromes caused by mutations in epigenetic genes.

Authors:  María Berdasco; Manel Esteller
Journal:  Hum Genet       Date:  2013-01-31       Impact factor: 4.132

Review 5.  Complex Phenotypes: Mechanisms Underlying Variation in Human Stature.

Authors:  Pushpanathan Muthuirulan; Terence D Capellini
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

6.  Natural antisense transcripts as therapeutic targets.

Authors:  Paul Halley; Olga Khorkova; Claes Wahlestedt
Journal:  Drug Discov Today Ther Strateg       Date:  2013

Review 7.  Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors.

Authors:  Laila C Schenkel; David Rodenhiser; Victoria Siu; Elizabeth McCready; Peter Ainsworth; Bekim Sadikovic
Journal:  J Pediatr Genet       Date:  2016-11-08

Review 8.  A Clinical Review of Generalized Overgrowth Syndromes in the Era of Massively Parallel Sequencing.

Authors:  Benjamin Kamien; Anne Ronan; Gemma Poke; Ingrid Sinnerbrink; Gareth Baynam; Michelle Ward; William T Gibson; Tracy Dudding-Byth; Rodney J Scott
Journal:  Mol Syndromol       Date:  2018-01-25

9.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.

Authors:  María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong Cheung; Nazneen Rahman; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 10.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.